Table 1.

Patient Characteristics

Patient Characteristics
Median (Range) Age (y)	54 (20–65)
FLT3 Mutation Type
ITD	15 (83%)
TKD	2 (11%)
ITD/TKD	1 (6%)
FLT3 Mutation Burden
Higha	13 (72%)
Low	5 (28%)
Eastern Cooperative Oncology Group Performance Status
0	5 (28%)
1	10 (55%)
2	2 (11%)
3	1 (6%)
Median (Range) White Blood Cell Count (×109/L)	18 (1.4–196)
Median (Range) Hemoglobin (g/dL)	8.5 (6.9–10.8)
Median (Range) Platelet (×109/L)	51.5 (18–189)
Cytogenetics
Diploid	10 (55%)
Other	8 (45%)

^a≥25% blast-normalized mutation ratio (see Methods section).